EG13496A - Benzenesulfonamide derivatives and processes for their manufacture - Google Patents

Benzenesulfonamide derivatives and processes for their manufacture

Info

Publication number
EG13496A
EG13496A EG512/78A EG51278A EG13496A EG 13496 A EG13496 A EG 13496A EG 512/78 A EG512/78 A EG 512/78A EG 51278 A EG51278 A EG 51278A EG 13496 A EG13496 A EG 13496A
Authority
EG
Egypt
Prior art keywords
manufacture
processes
benzenesulfonamide derivatives
benzenesulfonamide
derivatives
Prior art date
Application number
EG512/78A
Other languages
English (en)
Inventor
Max Haropot
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Application granted granted Critical
Publication of EG13496A publication Critical patent/EG13496A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/56—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups bound to carbon atoms of six-membered aromatic rings and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/58—One oxygen atom, e.g. butenolide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/28—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EG512/78A 1977-08-18 1978-08-16 Benzenesulfonamide derivatives and processes for their manufacture EG13496A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19772737195 DE2737195A1 (de) 1977-08-18 1977-08-18 Benzolsulfonamidderivate und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
EG13496A true EG13496A (en) 1981-12-31

Family

ID=6016681

Family Applications (1)

Application Number Title Priority Date Filing Date
EG512/78A EG13496A (en) 1977-08-18 1978-08-16 Benzenesulfonamide derivatives and processes for their manufacture

Country Status (15)

Country Link
US (1) US4235918A (xx)
EP (1) EP0001051B1 (xx)
JP (1) JPS5444662A (xx)
AT (1) AT371109B (xx)
AU (1) AU519998B2 (xx)
CA (1) CA1117951A (xx)
DE (2) DE2737195A1 (xx)
DK (1) DK363578A (xx)
EG (1) EG13496A (xx)
ES (1) ES472528A1 (xx)
FI (1) FI782500A (xx)
HU (1) HU177456B (xx)
IL (1) IL55369A (xx)
IT (1) IT1098071B (xx)
ZA (1) ZA784689B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3323511A1 (de) * 1983-06-30 1985-01-10 Hoechst Ag, 6230 Frankfurt 2-keto-sulfonamide und verfahren zu ihrer herstellung
DE3323510A1 (de) * 1983-06-30 1985-01-10 Hoechst Ag, 6230 Frankfurt 2-ketosulfonamide und verfahren zu deren herstellung
DE3713757A1 (de) * 1987-04-24 1988-11-10 Hoechst Ag Benzolsulfonamidderivate und verfahren zu ihrer herstellung
DE10047110A1 (de) * 2000-09-22 2002-04-18 Bayer Ag Optisch aktive 2,5-Bisaryl-DELTA·1·-Pyrroline

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1361388A (en) * 1970-08-05 1974-07-24 Geistlich Soehne Ag Ny--sulphamoylaryl--pyrrolidines
GB1406882A (en) * 1972-04-28 1975-09-17 Leo Pharm Prod Ltd Benzoic acid derivatives and benzisptjoaup'e 1.1 dopxode derovatoves
FI325174A (xx) 1973-11-19 1975-05-20 Sandoz Ag
US3947460A (en) 1974-06-27 1976-03-30 Sandoz, Inc. 5-Hydroxy-5-substituted phenyl-pyrrolidones and piperidinones
DE2436263C2 (de) * 1974-07-27 1983-02-17 Hoechst Ag, 6000 Frankfurt Thiazolidinderivate und Verfahren zu ihrer Herstellung
US4125614A (en) * 1974-07-27 1978-11-14 Hoechst Aktiengesellschaft Thiazolidine derivatives
DE2533821A1 (de) * 1975-07-29 1977-02-17 Hoechst Ag Thiazolidinderivate und verfahren zu ihrer herstellung
DE2546165A1 (de) * 1975-10-15 1977-04-28 Hoechst Ag Thiazolidinderivate und verfahren zu ihrer herstellung
SE7700436L (sv) * 1976-01-17 1977-07-18 Hoechst Ag Tiazolidinderivat och forfarande for deras framstellning
SE7700500L (sv) * 1976-01-20 1977-07-21 Hoechst Ag Tiazolidinderivat och forfarande for deras framstellning
CH628622A5 (de) * 1976-12-24 1982-03-15 Ciba Geigy Ag Verfahren zur herstellung von neuen in 4-stellung substituierten 3-sulfamoylbenzoesaeuren.

Also Published As

Publication number Publication date
JPS5444662A (en) 1979-04-09
DK363578A (da) 1979-02-19
EP0001051B1 (de) 1981-02-11
IT1098071B (it) 1985-08-31
AU3900778A (en) 1980-02-21
HU177456B (en) 1981-10-28
EP0001051A2 (de) 1979-03-21
AT371109B (de) 1983-06-10
IL55369A0 (en) 1978-10-31
FI782500A (fi) 1979-02-19
IT7826779A0 (it) 1978-08-16
DE2737195A1 (de) 1979-03-01
IL55369A (en) 1984-05-31
AU519998B2 (en) 1982-01-07
US4235918A (en) 1980-11-25
DE2860471D1 (en) 1981-03-26
EP0001051A3 (en) 1979-04-04
ES472528A1 (es) 1979-10-01
ZA784689B (en) 1979-08-29
ATA598578A (de) 1982-10-15
CA1117951A (en) 1982-02-09

Similar Documents

Publication Publication Date Title
AU526333B2 (en) Dephem derivatives and processes for their manufacture
IL54407A0 (en) Cephem derivatives and processes for their manufacture
GB2000153B (en) Cyclopentadienyl-metal compounds and processes for their preparation
SG7192G (en) Phenoxy-amino-propanols and processes for their preparation
JPS5481266A (en) 11alkanoyllpyrroline derivatives*manufacture and use
GB2003876B (en) Beta-haloethylamine derivatives
EG13762A (en) Cephalosporin derivatives and processes for their manufacture
EG13665A (en) 2-imino-imidazolidine derivatives
AU3888578A (en) 4-hydroxy-2-benzimidazolinone derivatives
ZA783430B (en) New nitroso-urea derivatives and processes for producing them
PH14637A (en) Oxadiazolopyrimidine derivatives
GB2005261B (en) 2-oxazolydone derivatives
EG13496A (en) Benzenesulfonamide derivatives and processes for their manufacture
PH14953A (en) Azetizinons derivatives and production thereof
GB2003479B (en) 3-amino-17alpha-aza-d-homoandrostane derivatives
AU3313978A (en) Everninomicin derivatives
JPS5448753A (en) Digoxigenine derivatives and manufacture
ZA785005B (en) 2-guanidinomethyl-indolines and processes for their preparation
GB2000128B (en) 15-substituted-omega-pentanorprostaglandin derivatives
ZA781103B (en) Novel aryl-hexafuranosides and processes for their preparation
GB2000769A (en) 4 - homoisotwistane derivatives
GB2008119B (en) Arylsteroid derivatives
AU4129978A (en) Eburnamenine derivatives
GB2060630B (en) Pyrazinoquinoline derivatives
GB2080287B (en) 2-alkoxy-5-aminobenzene sulfonates and 5-diazo derivatives thereof